title: LQT1-phenotypes in hiPSC: Are we measuring the right thing?
authors: Department of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany; and DZHK (German Centre for Cardiovascular Research), German Centre for Cardiovascular Research, partner site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany t.christ@uke.de.
authors: Torsten
authors: T
authors: Christ
authors: Department of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany; and DZHK (German Centre for Cardiovascular Research), German Centre for Cardiovascular Research, partner site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.
authors: András
authors: A
authors: Horvath
authors: Department of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany; and DZHK (German Centre for Cardiovascular Research), German Centre for Cardiovascular Research, partner site Hamburg/Kiel/Lübeck, 20246 Hamburg, Germany.
authors: Thomas
authors: T
authors: Eschenhagen
mesh_terms: D006801:Humans; D057026:Induced Pluripotent Stem Cells / Q000502:physiology*; D029593:Jervell-Lange Nielsen Syndrome / Q000188:drug therapy* / Q000235:genetics* / Q000503:physiopathology*; D051657:KCNQ1 Potassium Channel / Q000235:genetics*; D008954:Models, Biological; D010641:Phenotype
chemical_list: D051657:KCNQ1 Potassium Channel